Dr Adam Stewart
Dr

Adam Stewart

Email: 

Background

Adam G. Stewart, BBiomedSci, MBBS (Hons), MPHTM, FRACP, FRCPA

Dr Adam Stewart is an Infectious Diseases Physician, Clinical Microbiologist and Physician-Scientist.

His research interests include clinical trials, new antimicrobials, diagnostics for infectious diseases, and infections involving transplant recipients and other immunocompromised patients.

Availability

Dr Adam Stewart is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Biomedical Science, Griffith University
  • Bachelor of Medicine and Surgery and Medical Science, Griffith University
  • Masters (Coursework) of Public Health and Tropical Medicine, James Cook University

Research interests

  • New Antimicrobials

    Pre-clinical and clinical research evaluating the efficacy of new antibacterial, antifungal and antiviral agents

  • Clinical Trials in Infectious Diseases

    Randomised controlled trials to identify better treatment options for the management of infectious diseases

  • Diagnostics in Infectious Diseases

    Evaluating the clinical utility of novel diagnostic platforms with regards to predicting risk of infection, pathogen identification and antimicrobial resistance testing

  • Infectious Complications in Transplant Recipients

    Improving surveillance, detection and management of infectious diseases in solid organ and haematopoietic stem cell transplant recipients

Search Professor Adam Stewart’s works on UQ eSpace

89 works between 2015 and 2025
All (89) Journal Article (86) Other Outputs (1) Conference Publication (2)

81 - 89 of 89 works

2019

Journal Article

The rise and rise of antimicrobial resistance in Gram-negative bacteria

Stewart, Adam, Wright, Hugh and Hajkowicz, Krispin (2019). The rise and rise of antimicrobial resistance in Gram-negative bacteria. Microbiology Australia, 40 (2), 62-65. doi: 10.1071/MA19018

The rise and rise of antimicrobial resistance in Gram-negative bacteria

2019

Journal Article

Rhodococcus equi infection: a diverse spectrum of disease

Stewart, Adam, Sowden, David, Caffery, Michael, Bint, Michael and Broom, Jennifer (2019). Rhodococcus equi infection: a diverse spectrum of disease. IDCases, 15 e00487, e00487. doi: 10.1016/j.idcr.2019.e00487

Rhodococcus equi infection: a diverse spectrum of disease

2018

Journal Article

Treatment of infections with OXA-48 producing Enterobacteriaceae

Stewart, Adam, Harris, Patrick, Henderson, Andrew and Paterson, David (2018). Treatment of infections with OXA-48 producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 62 (11) e01195-18, AAC.01195-18. doi: 10.1128/aac.01195-18

Treatment of infections with OXA-48 producing Enterobacteriaceae

2018

Journal Article

Heterogeneity in skin manifestations of spotted fever group rickettsial infection in Australia

Stewart, Adam and Hajkowicz, Krispin (2018). Heterogeneity in skin manifestations of spotted fever group rickettsial infection in Australia. The Australasian Journal of Dermatology, 59 (4), 349-351. doi: 10.1111/ajd.12828

Heterogeneity in skin manifestations of spotted fever group rickettsial infection in Australia

2018

Journal Article

Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

Stewart, A., Roberts, J. A., Wallis, S. C., Allworth, A. M., Legg, A. and McCarthy, K. L. (2018). Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program. International Journal of Antimicrobial Agents, 51 (6), 941-942. doi: 10.1016/j.ijantimicag.2018.02.008

Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

2017

Journal Article

Rickettsia Australis and Queensland tick typhus: a rickettsial spotted fever group infection in Australia

Stewart, Adam, Armstrong, Mark, Graves, Stephen and Hajkowicz, Krispin (2017). Rickettsia Australis and Queensland tick typhus: a rickettsial spotted fever group infection in Australia. American Journal of Tropical Medicine and Hygiene, 97 (1), 24-29. doi: 10.4269/ajtmh.16-0915

Rickettsia Australis and Queensland tick typhus: a rickettsial spotted fever group infection in Australia

2017

Journal Article

Clinical manifestations and outcomes of Rickettsia australis infection: a 15-year retrospective study of hospitalized patients

Stewart, Adam, Armstrong, Mark, Graves, Stephen and Hajkowicz, Krispin (2017). Clinical manifestations and outcomes of Rickettsia australis infection: a 15-year retrospective study of hospitalized patients. Tropical Medicine and Infectious Disease, 2 (2) 19, 19. doi: 10.3390/tropicalmed2020019

Clinical manifestations and outcomes of Rickettsia australis infection: a 15-year retrospective study of hospitalized patients

2017

Journal Article

Epidemiology and characteristics of Rickettsia australis (Queensland tick typhus) infection in hospitalized patients in North Brisbane, Australia

Stewart, Adam, Armstrong, Mark, Graves, Stephen and Hajkowicz, Krispin (2017). Epidemiology and characteristics of Rickettsia australis (Queensland tick typhus) infection in hospitalized patients in North Brisbane, Australia. Tropical Medicine and Infectious Disease, 2 (2) 10, 10. doi: 10.3390/tropicalmed2020010

Epidemiology and characteristics of Rickettsia australis (Queensland tick typhus) infection in hospitalized patients in North Brisbane, Australia

2015

Journal Article

The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant enterobacter osteomyelitis

Stewart, Adam, Graves, Bianca, Hajkowicz, Krispin, Ta, Kim and Paterson, David L. (2015). The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant enterobacter osteomyelitis. Microbial Drug Resistance, 21 (6), 631-635. doi: 10.1089/mdr.2015.0006

The use of therapeutic drug monitoring to optimize treatment of carbapenem-resistant enterobacter osteomyelitis

Current funding

  • 2020 - 2025
    COVID-19 Cure Research (Paterson)
    Royal Brisbane and Women's Hospital Foundation
    Open grant

Past funding

  • 2020 - 2022
    Assessing in vitro activity of oral third generation cephalosporin / beta-lactamase inhibitor combinations against extended spectrum beta-lactamase (ESBL) producing uropathogens
    The Royal College of Pathologists of Australasia
    Open grant
  • 2020 - 2021
    USE OF THERAPEUTIC DRUG MONITORING (TDM) TO OPTIMISE ORAL/ENTERAL HYDROXYCHLOROQUINE DOSING IN CRITICALLY ILL PATIENTS WITH COVID-19 (MRFF CRR Respiratory Medicine administered by QUT)
    Queensland University of Technology
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on gut microbiota of hospitalized patients
    Avant Mutual Group Limited
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on the gut microbiome of hospitalized patients
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3
    Merck Sharp & Dohme Australia
    Open grant
  • 2018 - 2021
    A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales
    Junior Doctor Research Fellowships
    Open grant

Availability

Dr Adam Stewart is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Enquiries

Contact Dr Adam Stewart directly for media enquiries about:

  • clinical trial
  • infectious diseases
  • superbugs

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au